VYD-2311 is under clinical development by Invivyd and currently in Phase I for Coronavirus Disease 2019 (COVID-19).

Simaravibart is under clinical development by Contraria Biotech and currently in Phase III for Coronavirus Disease 2019 (COVID-19).

Merck & Co.’s Covid-19 antivirals are getting a new lease of life in post-pandemic China, as cat owners seize on them as ...

The World Health Organisation (WHO) has issued advice following a surge in hMPV cases in China, with the disease also on the ...

Five years ago, a cluster of people in Wuhan, China, fell sick with a virus never before seen in the world. The germ didn’t ...

An Infectious Disease Specialist recalls what we have learned after Covid was first identified five years ago.

Wen: The majority of people with diarrhea, vomiting and stomach cramps have viral gastroenteritis caused by the very ...

FOR most, mention of the Black Death probably conjures up medieval images of people dying horrifically in the street and Caused by the bacterium Yersinia pestis, the bubonic plague has killed ...

Authorities in Beijing have downplayed surge in cases, which comes five years after world was first alerted to emergence of ...

Officials have warned multiple flu-like illnesses are on the rise, with suggestions that 7.2% of outpatient visits to local ...